Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-002 · Safety alerts
SAFE-GLY-001: Diabetes-Range Laboratory Finding
Diabetes-Range Laboratory Finding. Fires when (hemoglobin_a1c at or above 6.5 AND a1c_interference_present is not true) OR (fasting_plasma_glucose at or above 126 AND fasting_confirmed) OR (ogtt_75g_glucose_2h at or above 200 AND ogtt_protocol_confirmed).
Condition
- (hemoglobin_a1c >= 6.5 AND a1c_interference_present != true) OR (fasting_plasma_glucose >= 126 AND fasting_confirmed) OR (ogtt_75g_glucose_2h >= 200 AND ogtt_protocol_confirmed)
Output
- DIABETES_RANGE_FINDING_REQUIRES_PHYSICIAN_REVIEW
States it sets
- glycemic state = GLY-DIABETES-RANGE
- safety state = SAFE-PRIORITY-REVIEW
Evidence
- EV-ADA-2026-DIAGAmerican Diabetes Association Professional Practice Committee for Diabetes. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27-S49.Supports: Prediabetes criteria based on A1C, fasting plasma glucose, and 2-hour plasma glucose after 75-g OGTT. Diabetes-range findings based on A1C, fasting plasma glucose, OGTT, or symptomatic random plasma glucose.
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.
